Jazz Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.

About JAZZ

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. 

CEO
Bruce C. Cozadd
CEOBruce C. Cozadd
Employees
2,800
Employees2,800
Headquarters
Dublin, Dublin
HeadquartersDublin, Dublin
Founded
2005
Founded2005
Employees
2,800
Employees2,800

JAZZ Key Statistics

Market cap
6.71B
Market cap6.71B
Price-Earnings ratio
14.76
Price-Earnings ratio14.76
Dividend yield
Dividend yield
Average volume
842.08K
Average volume842.08K
High today
High today
Low today
Low today
Open price
$109.89
Open price$109.89
Volume
0.00
Volume0.00
52 Week high
$148.06
52 Week high$148.06
52 Week low
$95.49
52 Week low$95.49

JAZZ News

Seeking Alpha 4d
Jazz Pharmaceuticals succeeds in late-stage study of lung cancer treatment

Jazz Pharmaceuticals (NASDAQ:JAZZ) said on Monday that the company's late-stage study of Zepzelca in combination with atezolizumab in small cell lung cancer tre...

Jazz Pharmaceuticals succeeds in late-stage study of lung cancer treatment

Analyst ratings

95%

of 19 ratings
Buy
94.7%
Hold
5.3%
Sell
0%

People also own

Based on the portfolios of people who own JAZZ. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.